Cogent Biosciences Stock Price History
| COGT Stock | USD 7.29 0.10 1.35% |
Below is the normalized historical share price chart for Cogent Biosciences extending back to March 29, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cogent Biosciences stands at 7.29, as last reported on the 20th of March, with the highest price reaching 7.41 and the lowest price hitting 7.27 during the day.
If you're considering investing in Cogent Stock, it is important to understand the factors that can impact its price. Cogent Biosciences secures Sharpe Ratio (or Efficiency) of -0.0124, which signifies that the company had a -0.0124 % return per unit of risk over the last 3 months. Cogent Biosciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cogent Biosciences' Risk Adjusted Performance of (0.05), mean deviation of 3.12, and Standard Deviation of 3.99 to double-check the risk estimate we provide.
At this time, Cogent Biosciences' Common Stock Shares Outstanding is comparatively stable compared to the past year. Common Stock Total Equity is likely to gain to about 84.5 K in 2025, whereas Capital Stock is likely to drop slightly above 68.1 M in 2025. . At this time, Cogent Biosciences' Price To Sales Ratio is comparatively stable compared to the past year. Price Book Value Ratio is likely to gain to 3.48 in 2025, whereas Price To Operating Cash Flows Ratio is likely to drop (2.89) in 2025. Cogent Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 29th of March 2018 | 200 Day MA 9.2424 | 50 Day MA 8.0087 | Beta 0.078 |
Cogent |
Sharpe Ratio = -0.0124
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | COGT |
Estimated Market Risk
| 3.87 actual daily | 34 66% of assets are more volatile |
Expected Return
| -0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cogent Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cogent Biosciences by adding Cogent Biosciences to a well-diversified portfolio.
Price Book 5.7712 | Enterprise Value Ebitda (3.89) | Price Sales 1.3 K | Shares Float 70 M | Wall Street Target Price 16.5 |
Cogent Biosciences Stock Price History Chart
There are several ways to analyze Cogent Stock price data. The simplest method is using a basic Cogent candlestick price chart, which shows Cogent Biosciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 5, 2025 | 9.66 |
| Lowest Price | February 26, 2025 | 6.71 |
Cogent Biosciences March 20, 2025 Stock Price Synopsis
Various analyses of Cogent Biosciences' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cogent Stock. It can be used to describe the percentage change in the price of Cogent Biosciences from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cogent Stock.| Cogent Biosciences Price Action Indicator | (0.10) | |
| Cogent Biosciences Price Daily Balance Of Power | (0.71) | |
| Cogent Biosciences Price Rate Of Daily Change | 0.99 | |
| Cogent Biosciences Accumulation Distribution | 9,378 |
Cogent Biosciences March 20, 2025 Stock Price Analysis
Cogent Stock Price History Data
The price series of Cogent Biosciences for the period between Fri, Dec 20, 2024 and Thu, Mar 20, 2025 has a statistical range of 2.95 with a coefficient of variation of 8.66. The prices are distributed with arithmetic mean of 8.01. The median price for the last 90 days is 8.03. The company had 1:4 stock split on 9th of November 2020. Cogent Biosciences issued dividends on 2020-11-09.| Open | High | Low | Close | Volume | ||
| 03/20/2025 | 7.39 | 7.41 | 7.27 | 7.29 | 496,358 | |
| 03/19/2025 | 7.23 | 7.49 | 7.20 | 7.39 | 532,565 | |
| 03/18/2025 | 7.24 | 7.40 | 7.17 | 7.25 | 694,230 | |
| 03/17/2025 | 7.13 | 7.49 | 6.95 | 7.39 | 953,745 | |
| 03/14/2025 | 7.38 | 7.50 | 7.07 | 7.14 | 633,139 | |
| 03/13/2025 | 7.55 | 7.87 | 7.20 | 7.29 | 1,234,999 | |
| 03/12/2025 | 7.33 | 7.76 | 7.30 | 7.59 | 754,904 | |
| 03/11/2025 | 6.83 | 7.28 | 6.61 | 7.24 | 1,227,801 | |
| 03/10/2025 | 6.86 | 7.03 | 6.60 | 6.85 | 1,141,565 | |
| 03/07/2025 | 7.45 | 7.48 | 6.90 | 7.01 | 944,580 | |
| 03/06/2025 | 7.55 | 7.71 | 7.28 | 7.41 | 659,771 | |
| 03/05/2025 | 7.23 | 7.76 | 7.18 | 7.67 | 1,309,510 | |
| 03/04/2025 | 6.90 | 7.28 | 6.79 | 7.17 | 1,005,810 | |
| 03/03/2025 | 7.55 | 7.63 | 6.99 | 7.00 | 1,494,667 | |
| 02/28/2025 | 6.97 | 7.56 | 6.92 | 7.53 | 1,834,056 | |
| 02/27/2025 | 6.74 | 7.35 | 6.68 | 6.99 | 2,772,725 | |
| 02/26/2025 | 7.22 | 7.24 | 6.56 | 6.71 | 1,604,066 | |
| 02/25/2025 | 7.44 | 7.47 | 6.84 | 6.99 | 2,510,458 | |
| 02/24/2025 | 8.00 | 8.00 | 7.45 | 7.46 | 1,304,394 | |
| 02/21/2025 | 8.18 | 8.23 | 7.89 | 8.00 | 963,166 | |
| 02/20/2025 | 8.14 | 8.14 | 7.88 | 8.09 | 615,023 | |
| 02/19/2025 | 8.01 | 8.16 | 7.96 | 8.08 | 575,247 | |
| 02/18/2025 | 7.99 | 8.29 | 7.95 | 8.10 | 770,438 | |
| 02/14/2025 | 8.24 | 8.37 | 7.98 | 8.03 | 841,352 | |
| 02/13/2025 | 8.16 | 8.25 | 7.96 | 8.18 | 857,839 | |
| 02/12/2025 | 8.24 | 8.34 | 7.96 | 8.14 | 1,260,977 | |
| 02/11/2025 | 8.62 | 8.76 | 8.06 | 8.42 | 1,281,723 | |
| 02/10/2025 | 8.78 | 8.96 | 8.63 | 8.76 | 787,994 | |
| 02/07/2025 | 9.14 | 9.28 | 8.72 | 8.74 | 744,184 | |
| 02/06/2025 | 9.63 | 9.72 | 9.04 | 9.17 | 3,889,787 | |
| 02/05/2025 | 9.26 | 9.93 | 9.14 | 9.66 | 1,063,377 | |
| 02/04/2025 | 8.96 | 9.30 | 8.94 | 9.25 | 993,134 | |
| 02/03/2025 | 9.25 | 9.25 | 8.93 | 8.99 | 1,077,216 | |
| 01/31/2025 | 9.79 | 9.79 | 8.99 | 9.31 | 1,965,786 | |
| 01/30/2025 | 9.67 | 10.15 | 9.55 | 9.62 | 1,518,647 | |
| 01/29/2025 | 8.84 | 9.46 | 8.84 | 9.30 | 1,422,563 | |
| 01/28/2025 | 8.49 | 9.02 | 8.28 | 8.93 | 1,834,779 | |
| 01/27/2025 | 8.49 | 8.72 | 8.30 | 8.47 | 1,764,319 | |
| 01/24/2025 | 8.83 | 8.93 | 8.24 | 8.35 | 1,441,635 | |
| 01/23/2025 | 8.15 | 9.03 | 7.90 | 8.89 | 2,219,651 | |
| 01/22/2025 | 8.28 | 8.33 | 8.10 | 8.20 | 1,015,994 | |
| 01/21/2025 | 8.05 | 8.24 | 7.74 | 8.20 | 1,474,403 | |
| 01/17/2025 | 8.24 | 8.30 | 7.84 | 8.03 | 1,160,620 | |
| 01/16/2025 | 8.17 | 8.44 | 8.00 | 8.13 | 2,001,520 | |
| 01/15/2025 | 8.00 | 8.72 | 7.80 | 8.12 | 2,743,644 | |
| 01/14/2025 | 7.61 | 7.70 | 7.19 | 7.37 | 2,030,578 | |
| 01/13/2025 | 7.79 | 7.82 | 6.60 | 7.57 | 2,447,433 | |
| 01/10/2025 | 7.90 | 7.97 | 7.67 | 7.84 | 1,775,139 | |
| 01/08/2025 | 8.20 | 8.44 | 8.05 | 8.11 | 1,150,209 | |
| 01/07/2025 | 8.07 | 8.38 | 8.03 | 8.25 | 896,025 | |
| 01/06/2025 | 7.92 | 8.57 | 7.91 | 8.06 | 1,025,412 | |
| 01/03/2025 | 7.87 | 8.20 | 7.72 | 7.88 | 1,270,971 | |
| 01/02/2025 | 7.90 | 8.01 | 7.63 | 7.80 | 1,200,245 | |
| 12/31/2024 | 7.78 | 7.82 | 7.39 | 7.80 | 1,698,682 | |
| 12/30/2024 | 7.67 | 7.75 | 7.45 | 7.71 | 1,011,364 | |
| 12/27/2024 | 7.78 | 7.86 | 7.60 | 7.74 | 927,724 | |
| 12/26/2024 | 7.79 | 7.90 | 7.66 | 7.87 | 835,523 | |
| 12/24/2024 | 7.75 | 7.88 | 7.62 | 7.86 | 537,249 | |
| 12/23/2024 | 7.81 | 7.93 | 7.42 | 7.76 | 1,318,259 | |
| 12/20/2024 | 7.71 | 8.06 | 7.68 | 7.84 | 2,668,265 | |
| 12/19/2024 | 7.65 | 7.92 | 7.37 | 7.80 | 1,573,735 |
About Cogent Biosciences Stock history
Cogent Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cogent is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cogent Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cogent Biosciences stock prices may prove useful in developing a viable investing in Cogent Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 73.3 M | 77 M | |
| Net Loss | -126.2 M | -132.5 M |
Cogent Biosciences Quarterly Net Working Capital |
|
Cogent Biosciences Stock Technical Analysis
Cogent Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Alpha Finder Now
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk |
| All Next | Launch Module |
Cogent Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cogent Biosciences' price direction in advance. Along with the technical and fundamental analysis of Cogent Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cogent to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.15) | |||
| Total Risk Alpha | 0.0627 | |||
| Treynor Ratio | (0.17) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Cogent Stock Analysis
When running Cogent Biosciences' price analysis, check to measure Cogent Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cogent Biosciences is operating at the current time. Most of Cogent Biosciences' value examination focuses on studying past and present price action to predict the probability of Cogent Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cogent Biosciences' price. Additionally, you may evaluate how the addition of Cogent Biosciences to your portfolios can decrease your overall portfolio volatility.